November/December 2015
Biopharma Asia
November/December 2015 | Volume 4 Issue 6
Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics
By: Dr Jincai Li, Executive Director, Biologics Process Development, Wuxi AppTec, China....
Current Developments with Disposable Technology and Single-Use Systems for Aseptic Process...
By: Tim Sandle, Head of Microbiology BPL
What is holding Industry back from Implementing Continuous Processing: Can Asia Adopt Mor...
By: Morten Munk, Senior Technology Partner Global Business Development, NNE Pharmaplan, Ge...
Culture of Pharmaceutical Quality: Improving Quality Management System
By: Ajaz S. Hussain, Ph.D. Insight Advice and Solutions LLC. Frederick, MD 21702, USA*, an...
Use of cyclodextrin to achieve a taste masked, bioequivalent Cetirizine HCl 10mg Zydis® d...
By: L. Grother, K. Hau, P. Axe, J.F. Baker Catalent
Neusilin®-Polymer Extrudates for the Development of Amorphous Solid Dispersions
University of Greenwich
SYLOID® XDP Silica: Optimised for Liquisolid and Lipid-based Formulations
Grace
Development and evaluation of a research screening assay to elucidate potential endogenous...
By: Randall Logan1, Sirantha Perera1, J.D. Pipkin2 and Jeffrey P. Krise1,* Captisol 1Depar...
Improvement of Physical Stability of Soft Gelatin Capsules by Film Coating
By: Yinqi Zhou and Irena McGuffy Catalent
















